טוען...
Power and Sample Size Calculations for SNP Association Studies with Censored Time-to-Event Outcomes
For many clinical studies in cancer, germline DNA is prospectively collected for the purpose of discovering or validating Single Nucleotide Polymorphisms associated with clinical outcomes. The primary clinical endpoint for many of these studies are time-to-event outcomes such as time of death or dis...
שמור ב:
| Main Authors: | , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2012
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3592339/ https://ncbi.nlm.nih.gov/pubmed/22685040 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/gepi.21645 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|